Clinical Laserthermia Systems AB (publ) (CLS-B) — Net Asset Quality Index
Clinical Laserthermia Systems AB (publ) (CLS-B) has a Net Asset Quality Index of 66.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr66.57 Million minus total liabilities of Skr22.07 Million yields net assets of Skr44.50 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does Clinical Laserthermia Systems AB (publ) carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Clinical Laserthermia Systems AB (publ) Net Asset Quality Index Over Time (2008–2025)
This chart shows how Clinical Laserthermia Systems AB (publ)'s Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the index stands at 66.8%, representing net assets of Skr44.50 Million against total assets of Skr66.57 Million SEK. For live market cap and overall valuation, see Clinical Laserthermia Systems AB (publ) market capitalisation.
Annual Net Asset Quality Index for Clinical Laserthermia Systems AB (publ) (2008–2025)
The table below presents the year-by-year Net Asset Quality Index for Clinical Laserthermia Systems AB (publ) from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check asset allocation strategy of Clinical Laserthermia Systems AB (publ) to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.9% | Skr66.48 Million | Skr76.49 Million | Skr10.00 Million | ▲ +3.3 pp |
| 2024 | 83.6% | Skr65.69 Million | Skr78.56 Million | Skr12.88 Million | ▲ +8.2 pp |
| 2023 | 75.4% | Skr43.53 Million | Skr57.73 Million | Skr14.20 Million | ▲ +59.5 pp |
| 2022 | 15.9% | Skr7.87 Million | Skr49.51 Million | Skr41.64 Million | ▼ -15.9 pp |
| 2021 | 31.7% | Skr21.18 Million | Skr66.74 Million | Skr45.55 Million | ▲ +0.4 pp |
| 2020 | 31.4% | Skr13.93 Million | Skr44.40 Million | Skr30.47 Million | ▲ +13.3 pp |
| 2019 | 18.1% | Skr7.00 Million | Skr38.67 Million | Skr31.67 Million | ▼ -67.7 pp |
| 2018 | 85.8% | Skr49.81 Million | Skr58.02 Million | Skr8.21 Million | ▲ +12.4 pp |
| 2017 | 73.4% | Skr33.00 Million | Skr44.94 Million | Skr11.94 Million | ▲ +10.9 pp |
| 2016 | 62.5% | Skr17.06 Million | Skr27.30 Million | Skr10.24 Million | ▼ -24.9 pp |
| 2015 | 87.4% | Skr19.46 Million | Skr22.27 Million | Skr2.81 Million | ▲ +2.0 pp |
| 2014 | 85.4% | Skr31.58 Million | Skr36.95 Million | Skr5.38 Million | ▼ -3.9 pp |
| 2013 | 89.4% | Skr26.09 Million | Skr29.20 Million | Skr3.11 Million | ▲ +4.1 pp |
| 2012 | 85.2% | Skr17.09 Million | Skr20.06 Million | Skr2.97 Million | ▲ +1.9 pp |
| 2011 | 83.3% | Skr10.83 Million | Skr13.01 Million | Skr2.17 Million | ▼ -4.8 pp |
| 2010 | 88.1% | Skr10.36 Million | Skr11.76 Million | Skr1.41 Million | ▲ +7.2 pp |
| 2009 | 80.8% | Skr6.63 Million | Skr8.20 Million | Skr1.57 Million | ▲ +14.2 pp |
| 2008 | 66.6% | Skr3.68 Million | Skr5.52 Million | Skr1.85 Million | — |